Penumbra, Inc. (NYSE:PEN) Shares Sold by Nomura Holdings Inc.

Nomura Holdings Inc. lessened its holdings in shares of Penumbra, Inc. (NYSE:PEN - Free Report) by 43.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 10,052 shares of the company's stock after selling 7,643 shares during the period. Nomura Holdings Inc.'s holdings in Penumbra were worth $2,387,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Norges Bank acquired a new stake in shares of Penumbra during the 4th quarter valued at approximately $54,396,000. T. Rowe Price Investment Management Inc. increased its stake in Penumbra by 47.4% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 707,061 shares of the company's stock valued at $167,913,000 after purchasing an additional 227,506 shares in the last quarter. Baillie Gifford & Co. raised its holdings in Penumbra by 23.4% during the fourth quarter. Baillie Gifford & Co. now owns 730,233 shares of the company's stock worth $173,416,000 after purchasing an additional 138,387 shares during the last quarter. Adage Capital Partners GP L.L.C. acquired a new position in Penumbra during the fourth quarter worth $23,866,000. Finally, Baird Financial Group Inc. boosted its position in Penumbra by 43.9% during the fourth quarter. Baird Financial Group Inc. now owns 280,198 shares of the company's stock worth $66,541,000 after purchasing an additional 85,542 shares in the last quarter. Institutional investors and hedge funds own 88.88% of the company's stock.

Insider Buying and Selling at Penumbra

In related news, Director Thomas Wilder sold 360 shares of the business's stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $264.58, for a total value of $95,248.80. Following the completion of the sale, the director now directly owns 4,533 shares in the company, valued at approximately $1,199,341.14. The trade was a 7.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Johanna Roberts sold 600 shares of the company's stock in a transaction that occurred on Tuesday, April 1st. The stock was sold at an average price of $269.11, for a total transaction of $161,466.00. Following the transaction, the executive vice president now directly owns 66,353 shares of the company's stock, valued at $17,856,255.83. This trade represents a 0.90% decrease in their position. The disclosure for this sale can be found here. Insiders sold 176,696 shares of company stock worth $50,207,745 in the last 90 days. 4.20% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Piper Sandler restated an "overweight" rating and issued a $330.00 price target (up previously from $250.00) on shares of Penumbra in a research report on Wednesday, February 19th. Royal Bank of Canada raised their target price on shares of Penumbra from $315.00 to $330.00 and gave the company an "outperform" rating in a report on Thursday, April 24th. UBS Group restated a "buy" rating and set a $330.00 target price (up previously from $320.00) on shares of Penumbra in a research report on Thursday, April 24th. Morgan Stanley upped their price target on shares of Penumbra from $240.00 to $260.00 and gave the company an "equal weight" rating in a report on Wednesday, February 19th. Finally, Truist Financial raised their price objective on shares of Penumbra from $315.00 to $330.00 and gave the stock a "buy" rating in a research note on Thursday, April 24th. Three equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $302.40.

Penumbra Trading Down 0.5%

PEN stock traded down $1.25 during midday trading on Thursday, hitting $269.14. The stock had a trading volume of 93,356 shares, compared to its average volume of 441,155. The company's 50-day moving average price is $280.00 and its 200 day moving average price is $264.45. The company has a debt-to-equity ratio of 0.02, a current ratio of 6.01 and a quick ratio of 3.25. The firm has a market cap of $10.42 billion, a PE ratio of 790.49, a price-to-earnings-growth ratio of 2.83 and a beta of 0.53. Penumbra, Inc. has a 12-month low of $148.00 and a 12-month high of $310.00.

Penumbra (NYSE:PEN - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The company reported $0.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.66 by $0.17. The business had revenue of $324.14 million for the quarter, compared to analysts' expectations of $315.72 million. Penumbra had a return on equity of 9.74% and a net margin of 1.17%. The business's revenue was up 16.3% on a year-over-year basis. During the same quarter last year, the firm earned $0.41 earnings per share. On average, equities research analysts predict that Penumbra, Inc. will post 3.67 earnings per share for the current fiscal year.

Penumbra Company Profile

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.